Cingulate: Precision Timed Release ADHD Drug Developer Files For IPO

September 14, 2021
4:53 pm

Cingulate: Precision Timed Release ADHD Drug Developer Files For IPO

Pheelings Media/iStock via Getty Images
About
Cingulate, Inc. (CING) is a clinical-stage biopharmaceutical company with a proprietary Precision Timed Release (PTR) drug delivery platform technology. The company, founded in 2013, aims to build “next-generation…

Click here to view the original article.

Global, Seeking Alpha

Share this article

Covenant Logistics Group (CVLG) Stock Valuation Check After Strong Recent Price Momentum

June 13, 2026

Dogecoin Surges Amid Growing Buzz Around SpaceX’s IPO

June 13, 2026

Space Stocks Got Crushed on SpaceX’s Big Day. Is the Sell-Off a Warning or a Buying Opportunity?

June 13, 2026

Here’s what Claude Fable 5 means for crypto and DeFi

June 13, 2026

This is not a crypto story and should not be published on CryptoBriefing

June 13, 2026

Securitize: A Crypto Use Case That Actually Works, And A Buy On Macro Tailwinds

June 13, 2026

BEATUSD- Audiera Delivers 208% Gain In Bearish Crypto Market

June 13, 2026

Kripicard Press Office Reports Growing Mainstream Demand for Crypto Payment Cards

June 13, 2026